Tavirant 200, 25, 25 mg Tablet
PDF Leaflet Revision Date: 19 September 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of adults infected with HIV-1 in combination with other antiretrovirals.
Dosage (summary)
One tablet daily with food for adults weighing at least 35 kg.
Special Populations
- Elderly patients
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy; breastfeeding is contraindicated.
Key Drug Interactions
- Carbamazepine
- Rifampicin
- Proton pump inhibitors
- St. John's wort
Contraindications
- Hypersensitivity to active substances
- Co-administration with certain anticonvulsants and antimycobacterials
Common side effects
- Nausea
- Diarrhoea
- Headache
- Dizziness
- Rash
Counselling Points
- Take with food
- Use effective contraception
- Monitor for opportunistic infections
Serious warnings
- Virologic failure and resistance development
- Immune reconstitution syndrome
- Lactic acidosis risk
On This Page
Connecting to Document Server
Decrypting and optimizing pharmaceutical leaflet...
Medinsert AI
Hello! I am Medinsert Ai. What would you like to know about this professional information leaftleft?
